News
16
Dec
What are the ESG materiality issues in the pharmaceutical sector in Switzerland?
Category: Blog
“The pharmaceutical sector in Switzerland is a major industry, accounting for approximately 7% of GDP, and 35% of manufacturing.” The Swiss pharma business is the largest pharma bu...